Association of Vascular Endothelial Growth Factor A +936 C/T Polymorphism With Non‐Alcoholic Fatty Liver Disease in a Bangladeshi Population: A Case‐Control Study
Health Science Reports · 2026-11 · 9 (11)
DOI: 10.1002/hsr2.73494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 05.11.2026. Verfasst von Rakibul Hasan Shanto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy University of Dhaka Dhaka Bangladesh. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Non‐Alcoholic Fatty Liver Disease (NAFLD) ranges from hepatic steatosis to advanced cirrhosis. Polymorphisms in the vascular endothelial growth factor A (VEGFA) gene can change its expression, potentially altering angiogenesis and advancing disease stage. This study aimed to evaluate the association between the VEGFA +936 C/T polymorphism and susceptibility to NAFLD in a Bangladeshi population.
Methods
A case‐control study was conducted including 100 NAFLD patients and 100 controls. NAFLD was diagnosed by ultrasonography. Genotyping was performed using allele‐specific polymerase chain reaction followed by gel electrophoresis. Biochemical parameters were measured using standard enzymatic methods following the manufacturer's instructions.
Results
The frequency of the T allele was significantly higher in NAFLD patients compared to controls (22.5% vs. 12%). The control genotype distribution was consistent with Hardy‐Weinberg equilibrium ( χ 2 = 0.2812, p = 0.60). The Cochran–Armitage trend test indicated an association between increasing T‐allele dosage and NAFLD ( Z = 2.68, p = 0.007). In logistic regression, the T‐allele was associated with NAFLD in the crude additive model (OR = 2.05, 95% CI: 1.20–3.51, p = 0.009) and after adjustment for age, sex, BMI, and fasting blood glucose (OR = 2.14, 95% CI: 1.13–4.08, p = 0.02). Under the dominant model, the association remained significant in both crude (OR = 2.27, 95% CI: 1.22–4.22, p = 0.01) and adjusted analyses (OR = 2.51, 95% CI: 1.18–5.33, p = 0.02). NAFLD patients showed significantly higher blood pressure, fasting blood glucose, HbA1c, total cholesterol, ALT, and AST, with lower HDL, while body mass index didn't differ significantly between groups.
Conclusion
This study demonstrated a significant association between the VEGFA +936 C/T polymorphism and susceptibility to NAFLD in a Bangladeshi population. However, due to the small sample size and limited number of TT individuals, further large‐scale and functional studies are required to validate these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy University of Dhaka Dhaka Bangladesh.
- Department of Pharmacy, Faculty of Biological Science and Technology Jashore University of Science and Technology Jashore Bangladesh.
- Department of Pharmacy University of Asia Pacific Dhaka Bangladesh.
- Department of Biotechnology, Faculty of Agriculture Bangladesh Agricultural University Mymensingh Bangladesh.
- Department of Hepatology Sher-E-Bangla Medical College Hospital Barishal Bangladesh.
- Department of Hepatology Bangladesh Medical University Dhaka Bangladesh.
ORCID-Profile: Rakibul Hasan Shanto, Imran Hossain, Ahmad Niaz Rahman, Fazle Rabbi, Anik Dhar, Sheikh Faisal Asadullah Mahdi, Tarhima Jahan Jerin, Md Samsul Arafin, Mamun Al Mahtab, Sheikh Zahir Raihan
Zitieren
APA
Shanto, R. H., Hossain, I., Rahman, A. N., Rabbi, F., Dhar, A., Mahdi, S. F. A., Jerin, T. J., Arafin, M. S., Al Mahtab, M., & Raihan, S. Z. (2026). Association of Vascular Endothelial Growth Factor A +936 C/T Polymorphism With Non‐Alcoholic Fatty Liver Disease in a Bangladeshi Population: A Case‐Control Study. Health Science Reports, 9(11). https://doi.org/10.1002/hsr2.73494
Vancouver
Shanto RH, Hossain I, Rahman AN, Rabbi F, Dhar A, Mahdi SFA, et al. Association of Vascular Endothelial Growth Factor A +936 C/T Polymorphism With Non‐Alcoholic Fatty Liver Disease in a Bangladeshi Population: A Case‐Control Study. Health Science Reports. 2026;9(11). doi:10.1002/hsr2.73494
BibTeX
@article{Shanto2026,
author = {Shanto, Rakibul Hasan and Hossain, Imran and Rahman, Ahmad Niaz and Rabbi, Fazle and Dhar, Anik and Mahdi, Sheikh Faisal Asadullah and Jerin, Tarhima Jahan and Arafin, Md Samsul and Al Mahtab, Mamun and Raihan, Sheikh Zahir},
title = {Association of Vascular Endothelial Growth Factor A +936 C/T Polymorphism With Non‐Alcoholic Fatty Liver Disease in a Bangladeshi Population: A Case‐Control Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {11},
doi = {10.1002/hsr2.73494}
}
EUVIMED